This is the third and final part of Drew Waight’s guest series evaluating NeurogesX for investment. Thanks to Drew! If anyone else would like to do a guest series about a recent IPO, shoot me an e-mail (it’s in the about section).
NeurogesX financial details (2006):
Burn Rate: $30million
Liquid Assets: $14million
IPO […]

Filed under: NeurogesX (NGSX) | 1 Comment »